image

Develop

Our funding programs support early stage, Ohio-based companies to achieve success.

Thermalin Diabetes, Inc.

Thermalin’s portfolio of next-generation insulin analogs fills multiple gaps in a rapidly growing $17B market. Thermalin’s world-class team is leveraging breakthroughs with significant IP built on 25 years of research on insulin by Dr. Michael Weiss, Chairman of Biochemistry at Case Western Reserve Medical School (CWRU). Our new molecules, novel formulations, and devices address unmet […]

view all clients

Global Cardiovascular Innovation Center